Li Ying, Xuan Jie, Song Yujun, Wang Ping, Qin Lidong
Department of Nanomedicine, Houston Methodist Research Institute, 6670 Bertner Avenue, Houston, TX 77030, USA.
Lab Chip. 2015 Aug 21;15(16):3300-6. doi: 10.1039/c5lc00529a.
Quantitative assays are of great importance for point-of-care (POC) diagnostics because they can offer accurate information on the analytes. However, current POC devices often require an accessory instrument to give quantitative readouts for protein biomarkers, especially for those at very low concentration levels. Here, we report a microfluidic platform, the digital volumetric bar-chart chip (DV-chip), for quantitative POC diagnostics with ultra-low detection limits that are readable with the naked eye. Requiring no calibration, the DV-chip presents a digital ink bar chart (representing multiple bits composed of 0 and 1) for the target biomarker based on direct competition between O2 generated by the experimental and control samples. The bar chart clearly and accurately defines target concentration, allowing identification of disease status. For the standard PtNP solutions, the detection limit of the platform is approximately 0.1 pM and the dynamic range covers four orders of magnitude from 0.1 to 1000 pM. CEA samples with concentrations of 1 ng mL(-1) and 1.5 ng mL(-1) could be differentiated by the device. We also performed the ELISA assay for B-type natriuretic peptide (BNP) in 20 plasma samples from heart failure patients and the obtained on-chip data were in agreement with the clinical results. In addition, BNP was detectable at concentrations of less than 5 pM, which is three orders of magnitude lower than the detection limit of the previously reported readerless digital methods. By the integration of gas competition, volumetric bar chart, and digital readout, the DV-chip possesses merits of portability, visible readout, and ultra-low detection limit, which should offer a powerful platform for quantitative POC diagnostics in clinical settings and personalized detection.
定量检测对于即时检测(POC)诊断非常重要,因为它们可以提供有关分析物的准确信息。然而,当前的即时检测设备通常需要辅助仪器来给出蛋白质生物标志物的定量读数,特别是对于那些浓度非常低的生物标志物。在这里,我们报告了一种微流控平台,即数字体积条形图芯片(DV芯片),用于具有超低检测限的定量即时检测诊断,该检测限可用肉眼读取。无需校准,DV芯片基于实验样品和对照样品产生的O2之间的直接竞争,为目标生物标志物呈现数字墨水条形图(代表由0和1组成的多个位)。条形图清晰准确地定义了目标浓度,从而可以识别疾病状态。对于标准的PtNP溶液,该平台的检测限约为0.1 pM,动态范围涵盖从0.1到1000 pM的四个数量级。该设备可以区分浓度为1 ng mL(-1)和1.5 ng mL(-1)的癌胚抗原(CEA)样品。我们还对20例心力衰竭患者的血浆样本进行了B型利钠肽(BNP)的酶联免疫吸附测定(ELISA),获得的芯片上数据与临床结果一致。此外,BNP在浓度低于5 pM时即可检测到,这比先前报道的无读数数字方法的检测限低三个数量级。通过气体竞争、体积条形图和数字读数的集成,DV芯片具有便携性、可见读数和超低检测限的优点,这应为临床环境中的定量即时检测诊断和个性化检测提供一个强大的平台。